STOCK TITAN

MindMed to Host Earnings Call to Discuss Second Quarter 2022 Financial Results and Provide Business Update

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) announced it will host an earnings call on August 11, 2022, at 4:30 p.m. EDT to discuss its financial results for the quarter ended June 30, 2022, alongside a business update. The company focuses on developing innovative products targeting brain health disorders, including psychiatry and addiction. Stakeholders can join the call via telephone or watch the webcast, which will also be archived for 30 days.

Positive
  • None.
Negative
  • None.

NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced that it will host its earnings call on Thursday, August 11, 2022, at 4:30 p.m. EDT to discuss its financial results for the quarter ended June 30, 2022 and provide a business update.

Individuals may participate via telephone by dialing (800) 920-2776 (domestic) or (416) 981-9033 (international) and using conference ID 22019820. The webcast can be accessed live here or on MindMed's Investor Resources webpage. The webcast will be archived on the company's website for at least 30 days after the conference call.

About MindMed

MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems.

MindMed trades on NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the symbol MMED.

For Media: media@mindmed.co

For Investors: ir@mindmed.co

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/mindmed-to-host-earnings-call-to-discuss-second-quarter-2022-financial-results-and-provide-business-update-301599817.html

SOURCE Mind Medicine (MindMed) Inc.

FAQ

When is MindMed's earnings call?

MindMed's earnings call is scheduled for August 11, 2022, at 4:30 p.m. EDT.

What financial results will MindMed discuss in the earnings call?

MindMed will discuss its financial results for the quarter ended June 30, 2022.

How can I participate in MindMed's earnings call?

You can participate by dialing (800) 920-2776 for domestic or (416) 981-9033 for international callers, using conference ID 22019820.

Mind Medicine (MindMed) Inc. Common Shares

NASDAQ:MNMD

MNMD Rankings

MNMD Latest News

MNMD Stock Data

524.69M
72.48M
1.14%
68.1%
13.61%
Biotechnology
Medicinal Chemicals & Botanical Products
Link
United States of America
NEW YORK